Zinc in PDB 3rnn: Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
Protein crystallography data
The structure of Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator, PDB code: 3rnn
was solved by
D.E.Timm,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
39.50 /
1.75
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
114.368,
163.856,
47.391,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.7 /
22.7
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
(pdb code 3rnn). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 5 binding sites of Zinc where determined in the
Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator, PDB code: 3rnn:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
Zinc binding site 1 out
of 5 in 3rnn
Go back to
Zinc Binding Sites List in 3rnn
Zinc binding site 1 out
of 5 in the Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn282
b:24.3
occ:1.00
|
OE2
|
B:GLU166
|
1.8
|
22.7
|
1.0
|
OE1
|
A:GLU42
|
2.0
|
22.4
|
1.0
|
NE2
|
A:HIS46
|
2.0
|
22.9
|
1.0
|
CD
|
B:GLU166
|
2.6
|
24.4
|
1.0
|
OE1
|
B:GLU166
|
2.7
|
25.7
|
1.0
|
CD
|
A:GLU42
|
3.0
|
23.8
|
1.0
|
CD2
|
A:HIS46
|
3.0
|
24.4
|
1.0
|
CE1
|
A:HIS46
|
3.0
|
25.6
|
1.0
|
OE2
|
A:GLU42
|
3.3
|
23.5
|
1.0
|
CD2
|
A:LEU241
|
4.1
|
23.9
|
1.0
|
CG
|
B:GLU166
|
4.1
|
24.9
|
1.0
|
ND1
|
A:HIS46
|
4.1
|
25.0
|
1.0
|
CG
|
A:HIS46
|
4.1
|
25.0
|
1.0
|
N
|
B:SER168
|
4.3
|
20.8
|
1.0
|
CG
|
A:GLU42
|
4.3
|
19.5
|
1.0
|
O
|
B:ALA165
|
4.6
|
20.9
|
1.0
|
CB
|
A:GLU42
|
4.6
|
18.4
|
1.0
|
CB
|
B:GLU166
|
4.7
|
22.5
|
1.0
|
CA
|
B:SER168
|
4.8
|
19.8
|
1.0
|
CB
|
B:SER168
|
4.8
|
19.9
|
1.0
|
C
|
B:PRO167
|
4.9
|
21.9
|
1.0
|
CA
|
B:GLU166
|
4.9
|
22.9
|
1.0
|
CA
|
B:PRO167
|
4.9
|
22.1
|
1.0
|
CD2
|
A:LEU246
|
5.0
|
27.6
|
1.0
|
|
Zinc binding site 2 out
of 5 in 3rnn
Go back to
Zinc Binding Sites List in 3rnn
Zinc binding site 2 out
of 5 in the Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn282
b:32.5
occ:1.00
|
NE2
|
B:HIS23
|
2.0
|
28.2
|
1.0
|
OE2
|
B:GLU30
|
2.1
|
30.7
|
1.0
|
CD
|
B:GLU30
|
2.8
|
30.8
|
1.0
|
OE1
|
B:GLU30
|
2.9
|
32.6
|
1.0
|
CD2
|
B:HIS23
|
2.9
|
27.8
|
1.0
|
CE1
|
B:HIS23
|
3.1
|
26.6
|
1.0
|
CG
|
B:HIS23
|
4.1
|
29.6
|
1.0
|
CD
|
B:LYS20
|
4.1
|
27.5
|
1.0
|
NZ
|
B:LYS20
|
4.1
|
27.9
|
1.0
|
ND1
|
B:HIS23
|
4.1
|
28.2
|
1.0
|
O
|
B:GLU30
|
4.3
|
26.4
|
1.0
|
CG
|
B:GLU30
|
4.3
|
29.5
|
1.0
|
CD1
|
B:LEU26
|
4.4
|
40.3
|
1.0
|
CE
|
B:LYS20
|
4.8
|
27.1
|
1.0
|
|
Zinc binding site 3 out
of 5 in 3rnn
Go back to
Zinc Binding Sites List in 3rnn
Zinc binding site 3 out
of 5 in the Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn283
b:24.1
occ:1.00
|
O
|
B:HOH478
|
1.9
|
26.9
|
1.0
|
NE2
|
B:HIS46
|
1.9
|
21.1
|
1.0
|
OE1
|
B:GLU42
|
2.0
|
22.6
|
1.0
|
CD
|
B:GLU42
|
2.9
|
23.1
|
1.0
|
CD2
|
B:HIS46
|
2.9
|
20.4
|
1.0
|
CE1
|
B:HIS46
|
2.9
|
23.3
|
1.0
|
OE2
|
B:GLU42
|
3.2
|
24.6
|
1.0
|
CD2
|
B:LEU241
|
3.7
|
21.6
|
1.0
|
OE1
|
B:GLN244
|
3.8
|
29.2
|
1.0
|
O
|
B:HOH376
|
3.9
|
43.0
|
1.0
|
CE
|
B:LYS45
|
3.9
|
26.3
|
1.0
|
NZ
|
B:LYS45
|
3.9
|
25.1
|
1.0
|
O
|
B:HOH656
|
4.0
|
48.7
|
1.0
|
ND1
|
B:HIS46
|
4.0
|
24.3
|
1.0
|
CG
|
B:HIS46
|
4.1
|
22.1
|
1.0
|
CG
|
B:GLU42
|
4.3
|
18.3
|
1.0
|
CB
|
B:GLU42
|
4.6
|
17.4
|
1.0
|
CD
|
B:GLN244
|
4.6
|
29.6
|
1.0
|
NE2
|
B:GLN244
|
4.6
|
30.3
|
1.0
|
|
Zinc binding site 4 out
of 5 in 3rnn
Go back to
Zinc Binding Sites List in 3rnn
Zinc binding site 4 out
of 5 in the Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn281
b:29.5
occ:1.00
|
O
|
C:HOH491
|
1.7
|
30.3
|
1.0
|
O
|
C:HOH490
|
1.9
|
36.9
|
1.0
|
OD2
|
C:ASP65
|
2.1
|
24.5
|
1.0
|
CG
|
C:ASP65
|
2.8
|
27.2
|
1.0
|
OD1
|
C:ASP65
|
2.8
|
29.7
|
1.0
|
O
|
C:HOH684
|
4.1
|
54.3
|
1.0
|
OD1
|
C:ASP67
|
4.2
|
40.4
|
1.0
|
CB
|
C:ASP65
|
4.2
|
26.1
|
1.0
|
CB
|
C:ASP67
|
4.6
|
34.7
|
1.0
|
CG
|
C:ASP67
|
4.9
|
37.3
|
1.0
|
O
|
C:HOH489
|
4.9
|
42.4
|
1.0
|
CG2
|
C:THR68
|
5.0
|
31.7
|
1.0
|
|
Zinc binding site 5 out
of 5 in 3rnn
Go back to
Zinc Binding Sites List in 3rnn
Zinc binding site 5 out
of 5 in the Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Crystal Structure of IGLUR2 Ligand Binding Domain with Symmetric Sulfonamide Containing Potentiator within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Zn282
b:53.4
occ:1.00
|
NE2
|
C:HIS46
|
2.0
|
40.8
|
1.0
|
OE1
|
C:GLU42
|
2.2
|
32.3
|
1.0
|
O
|
C:HOH806
|
2.6
|
47.8
|
1.0
|
CD2
|
C:HIS46
|
3.0
|
40.2
|
1.0
|
CE1
|
C:HIS46
|
3.0
|
41.3
|
1.0
|
CD
|
C:GLU42
|
3.2
|
33.3
|
1.0
|
OE2
|
C:GLU42
|
3.5
|
36.1
|
1.0
|
CE
|
C:LYS45
|
3.7
|
42.5
|
1.0
|
NZ
|
C:LYS45
|
3.8
|
44.8
|
1.0
|
CD2
|
C:LEU241
|
3.9
|
26.4
|
1.0
|
OE1
|
C:GLN244
|
4.1
|
37.3
|
1.0
|
ND1
|
C:HIS46
|
4.1
|
41.0
|
1.0
|
CG
|
C:HIS46
|
4.2
|
39.5
|
1.0
|
CD2
|
C:LEU246
|
4.3
|
34.2
|
1.0
|
CG
|
C:GLU42
|
4.5
|
29.1
|
1.0
|
CB
|
C:GLU42
|
4.7
|
27.3
|
1.0
|
NE2
|
C:GLN244
|
4.8
|
38.6
|
1.0
|
CD
|
C:GLN244
|
4.9
|
32.9
|
1.0
|
O
|
C:GLU42
|
5.0
|
28.1
|
1.0
|
|
Reference:
D.E.Timm,
M.Benveniste,
A.M.Weeks,
E.S.Nisenbaum,
K.M.Partin.
Structural and Functional Analysis of Two New Positive Allosteric Modulators of GLUA2 Desensitization and Deactivation. Mol.Pharmacol. V. 80 267 2011.
ISSN: ISSN 0026-895X
PubMed: 21543522
DOI: 10.1124/MOL.110.070243
Page generated: Sat Oct 26 14:58:11 2024
|